ASSESSMENT METHOD glycoprotein function in patients with ischemic heart disease, hypertension and type 2 diabetes

摘要

the method of assessment u0433u043bu0438u043au043eu043fu0440u043eu0442u0435u0438u043du043eu0432u044bu0445 functions u043eu0442u043bu0438u0447u0430u044eu0449u0438u0439u0441u00a0, however, that the u043au043eu0440u0440u0435u043bu00a0u0446u0438u043eu043du043du043eu0433u043e analysis (using the criteria u0441u0442u044au044eu0434u0435u043du0442u0430 fisher) between u043au043eu043du0446u0435u043du0442u0440u0430u0446u0438u00a0u043cu0438 u0433u043bu044e goat blood and u043fu043eu043au0430u0437u0430u0442u0435u043bu00a0u043cu0438 u043fu0440u043eu0442u0435u0438u043du043eu0433u0440u0430u043cu043cu044b (total protein, protein fraction), u043fu043eu0437u0432u043eu043bu00a0u0435u0442 to evaluate the characteristics of patients with coronary heart u0431u043eu043bu0435u0437 metabolic processes in the body new heart, arterial hypertension and diabetes mellitus type 2.